Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer

Jolien Heukelom; Olga Hamming; Harry Bartelink; Frank Hoebers; Jordi Giralt; Teresa Herlestam; Marcel Verheij; Michiel van den Brekel; Wouter Vogel; Nick Slevin; Eric Deutsch; Jan-Jakob Sonke; Philippe Lambin; Coen Rasch

doi:10.1186/1471-2407-13-84

Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer

Jolien Heukelom, Olga Hamming, Harry Bartelink, Frank Hoebers, Jordi Giralt, Teresa Herlestam, Marcel Verheij, Michiel van den Brekel, Wouter Vogel, Nick Slevin, Eric Deutsch, Jan-Jakob Sonke, Philippe Lambin, Coen Rasch

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	84
Journal	BMC Cancer
Volume	13
DOIs	https://doi.org/10.1186/1471-2407-13-84
Publication status	Published - 22 Feb 2013

Keywords

Head and neck
Squamous cell carcinoma
Adaptive radiotherapy
Dose painting
Zirconium
Cetuximab
Cisplatin

Access to Document

10.1186/1471-2407-13-84

Cite this

Heukelom, J., Hamming, O., Bartelink, H., Hoebers, F., Giralt, J., Herlestam, T., Verheij, M., van den Brekel, M., Vogel, W., Slevin, N., Deutsch, E., Sonke, J-J., Lambin, P., & Rasch, C. (2013). Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. BMC Cancer, 13, [84]. https://doi.org/10.1186/1471-2407-13-84

Heukelom, Jolien ; Hamming, Olga ; Bartelink, Harry ; Hoebers, Frank ; Giralt, Jordi ; Herlestam, Teresa ; Verheij, Marcel ; van den Brekel, Michiel ; Vogel, Wouter ; Slevin, Nick ; Deutsch, Eric ; Sonke, Jan-Jakob ; Lambin, Philippe ; Rasch, Coen. / Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. In: BMC Cancer. 2013 ; Vol. 13.

@article{19fe2bf6189040f192ba03ae3b7c4b2d,

title = "Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer",

keywords = "Head and neck, Squamous cell carcinoma, Adaptive radiotherapy, Dose painting, Zirconium, Cetuximab, Cisplatin",

author = "Jolien Heukelom and Olga Hamming and Harry Bartelink and Frank Hoebers and Jordi Giralt and Teresa Herlestam and Marcel Verheij and {van den Brekel}, Michiel and Wouter Vogel and Nick Slevin and Eric Deutsch and Jan-Jakob Sonke and Philippe Lambin and Coen Rasch",

year = "2013",

month = feb,

day = "22",

doi = "10.1186/1471-2407-13-84",

language = "English",

volume = "13",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd",

}

Heukelom, J, Hamming, O, Bartelink, H, Hoebers, F, Giralt, J, Herlestam, T, Verheij, M, van den Brekel, M, Vogel, W, Slevin, N, Deutsch, E, Sonke, J-J, Lambin, P & Rasch, C 2013, 'Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer', BMC Cancer, vol. 13, 84. https://doi.org/10.1186/1471-2407-13-84

Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. / Heukelom, Jolien; Hamming, Olga; Bartelink, Harry; Hoebers, Frank; Giralt, Jordi; Herlestam, Teresa; Verheij, Marcel; van den Brekel, Michiel; Vogel, Wouter; Slevin, Nick; Deutsch, Eric; Sonke, Jan-Jakob; Lambin, Philippe; Rasch, Coen.

In: BMC Cancer, Vol. 13, 84, 22.02.2013.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer

AU - Heukelom, Jolien

AU - Hamming, Olga

AU - Bartelink, Harry

AU - Hoebers, Frank

AU - Giralt, Jordi

AU - Herlestam, Teresa

AU - Verheij, Marcel

AU - van den Brekel, Michiel

AU - Vogel, Wouter

AU - Slevin, Nick

AU - Deutsch, Eric

AU - Sonke, Jan-Jakob

AU - Lambin, Philippe

AU - Rasch, Coen

PY - 2013/2/22

Y1 - 2013/2/22

KW - Head and neck

KW - Squamous cell carcinoma

KW - Adaptive radiotherapy

KW - Dose painting

KW - Zirconium

KW - Cetuximab

KW - Cisplatin

U2 - 10.1186/1471-2407-13-84

DO - 10.1186/1471-2407-13-84

M3 - Article

VL - 13

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 84

ER -